Gregory David Emil Mueller
Executive VP, General Counsel & Chief Legal OfficerMr. Gregory David Emil Mueller, also known as Greg, is Non-Executive Director of Merus N.V. since December 11, 2025. Mr. Mueller is Executive Vice President, General Counsel & Chief Legal Officer of Genmab A/S from July 1, 2025. He serves as the Deputy General Counsel International & Japan for AstraZeneca PLC and has the responsibility for managing all commercial legal risks for the company outside of the US, Canada and the EU. Mr. Mueller has geographic responsibility includes Asia-Pacific, the Middle-East & Africa, Russia & Eurasia and Latin America, a combined region in which AZ employs over 20,000 people and generates. He was a Non-Executive Director of AstraZeneca Pharma India Limited since December 02, 2016 until February 6, 2019. Prior to his tenure at AZ, he worked as a corporate transactions lawyer at a large national Canadian law firm. He holds a Bachelor of Commerce specialist degree from the University of Toronto and a Law Degree (LLB) from Queen's University.
Positions
- Company NameGenmab A/SStock CodeGMABPositionExecutive VP, General Counsel & Chief Legal OfficerColleagues
- JGJan G.J. van de WinkelCo-Founder, President & CEO
- DPDeirdre P. ConnellyIndependent Chairman of the Board
- APAnthony PaganoExecutive VP & CFO
- RWRayne WallerExecutive VP & Chief Technical Operations Officer
- CCChristopher CozicExecutive VP & Chief People Officer
- PEPernille ErenbjergIndependent Deputy Chairman
- MSMartin SchultzSenior Director, Head of Development Business Partnership & Strategy and Director
- MZMijke ZachariasseVP, Head of Antibody Research Materials & Director
- THTakahiro HamataniSenior Director of Finance Japan & Non-Independent Director
